Pharmacists in Bonita, California


13 Pharmacists found in Bonita
male pharmacist

Dr. Andrew Jess Morales, PHARM.D.


Pharmacist
3955 Bonita Rd, Bonita, CA 91902
619-409-6404     619-409-6410

female pharmacist

Christina Mancilla Jenkins, PHARM.D


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
3955 Bonita Rd, Bonita, CA 91902
619-409-6408     619-409-6410

male pharmacist

Mr. Duncan Jay Woo


Pharmacist
3955 Bonita Rd, Bonita, CA 91902
619-409-6404     619-406-6410



male pharmacist

Mr. James Thomas Lentz, PHARM D


Pharmacist
3955 Bonita Rd, Bonita, CA 91902
619-409-6404     619-409-6410

male pharmacist

James Tobitt, PHARM.D. MSL-BC


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
256 Surrey Dr, Bonita, CA 91902
619-434-2143    

female pharmacist

Julie Ann Ball, PHARMD


Pharmacist
3955 Bonita Rd, Bonita, CA 91902
619-409-6404    

female pharmacist

Miss Kelsie Kagawa


Pharmacist
4348 Bonita Rd, Bonita, CA 91902
619-267-1617    

female pharmacist

Kristi Lee


Pharmacist
4348 Bonita Road, Bonita, CA 91902
619-267-1729    

male pharmacist

Melad Sada, PHARMD


Pharmacist
3955 Bonita Rd, Bonita, CA 91902
619-409-6404    

female pharmacist

Michele Alaine Dumstorff, PHARM. D.


Pharmacist
3955 Bonita Rd, Bonita, CA 91902
619-409-6404     619-409-6410

female pharmacist

Thuy-tien Diep


Pharmacist
4348 Bonita Rd, Bonita, CA 91902
619-267-1617    

male pharmacist

Mr. Wai-chuen Mark Siu, RPH


Pharmacist
3955 Bonita Rd, Bonita, CA 91902
619-409-6404    

female pharmacist

Wonja Paik Kang, RPH


Pharmacist
3955 Bonita Rd, Bonita, CA 91902
619-409-6404    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.